183 related articles for article (PubMed ID: 32472411)
1. Downstaging with Radioembolization or Chemotherapy for Initially Unresectable Intrahepatic Cholangiocarcinoma.
Riby D; Mazzotta AD; Bergeat D; Verdure L; Sulpice L; Bourien H; Lièvre A; Rolland Y; Garin E; Boudjema K; Edeline J
Ann Surg Oncol; 2020 Oct; 27(10):3729-3737. PubMed ID: 32472411
[TBL] [Abstract][Full Text] [Related]
2. Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
Edeline J; Touchefeu Y; Guiu B; Farge O; Tougeron D; Baumgaertner I; Ayav A; Campillo-Gimenez B; Beuzit L; Pracht M; Lièvre A; Le Sourd S; Boudjema K; Rolland Y; Boucher E; Garin E
JAMA Oncol; 2020 Jan; 6(1):51-59. PubMed ID: 31670746
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
Le Roy B; Gelli M; Pittau G; Allard MA; Pereira B; Serji B; Vibert E; Castaing D; Adam R; Cherqui D; Sa Cunha A
Br J Surg; 2018 Jun; 105(7):839-847. PubMed ID: 28858392
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial yttrium-90 radioembolization combined with systemic chemotherapy is a promising method for downstaging unresectable huge intrahepatic cholangiocarcinoma to surgical treatment.
Rayar M; Sulpice L; Edeline J; Garin E; Levi Sandri GB; Meunier B; Boucher E; Boudjema K
Ann Surg Oncol; 2015 Sep; 22(9):3102-8. PubMed ID: 25623598
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety comparison of neoadjuvant chemotherapy followed by surgery and upfront surgery for treating intrahepatic cholangiocarcinoma: a systematic review and meta-analysis.
Yang Z; Jiang X
BMC Gastroenterol; 2023 Apr; 23(1):122. PubMed ID: 37046191
[TBL] [Abstract][Full Text] [Related]
6. Selective internal radiation therapy using yttrium-90 microspheres for treatment of localized and locally advanced intrahepatic cholangiocarcinoma.
Yu Q; Ungchusri E; Pillai A; Liao CY; Baker T; Fung J; DiSabato D; Zhang M; Liao C; Van Ha T; Ahmed O
Eur Radiol; 2024 Apr; 34(4):2374-2383. PubMed ID: 37812295
[TBL] [Abstract][Full Text] [Related]
7. Impact of Staging Concordance and Downstaging After Neoadjuvant Therapy on Survival Following Resection of Intrahepatic Cholangiocarcinoma: A Bayesian Analysis.
Alaimo L; Moazzam Z; Lima HA; Endo Y; Woldesenbet S; Ejaz A; Cloyd J; Guglielmi A; Ruzzenente A; Pawlik TM
Ann Surg Oncol; 2023 Aug; 30(8):4799-4808. PubMed ID: 37029867
[TBL] [Abstract][Full Text] [Related]
8. Yttrium-90 Radioembolization of Unresectable Intrahepatic Cholangiocarcinoma: Long-Term Follow-up for a 136-Patient Cohort.
Gupta AN; Gordon AC; Gabr A; Kalyan A; Kircher SM; Mahalingam D; Mulcahy MF; Merkow RP; Yang AD; Bentrem DJ; Caicedo-Ramirez JC; Riaz A; Thornburg B; Desai K; Sato KT; Hohlastos ES; Kulik L; Benson AB; Salem R; Lewandowski RJ
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1117-1128. PubMed ID: 35732931
[TBL] [Abstract][Full Text] [Related]
9. Transarterial Yttrium-90 Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis.
Schartz DA; Porter M; Schartz E; Kallas J; Gupta A; Butani D; Cantos A
J Vasc Interv Radiol; 2022 Jun; 33(6):679-686. PubMed ID: 35219834
[TBL] [Abstract][Full Text] [Related]
10. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies.
Reimer P; Vilgrain V; Arnold D; Balli T; Golfieri R; Loffroy R; Mosconi C; Ronot M; Sengel C; Schaefer N; Maleux G; Munneke G; Peynircioglu B; Sangro B; Kaufmann N; Urdaniz M; Pereira H; de Jong N; Helmberger T
Cardiovasc Intervent Radiol; 2024 Mar; 47(3):310-324. PubMed ID: 38321223
[TBL] [Abstract][Full Text] [Related]
11. Radioembolization with Yttrium-90 Glass Microspheres as a First-Line Treatment for Unresectable Intrahepatic Cholangiocarcinoma-A Prospective Feasibility Study.
Kis B; Shridhar R; Mhaskar R; Gyano M; Frakes JM; El-Haddad G; Choi J; Kim RD; Hoffe SE
J Vasc Interv Radiol; 2023 Sep; 34(9):1547-1555. PubMed ID: 37210030
[TBL] [Abstract][Full Text] [Related]
12. Yttrium-90 Radioembolization in Unresectable Intrahepatic Cholangiocarcinoma: Results of a Multicenter Retrospective Study.
Bargellini I; Mosconi C; Pizzi G; Lorenzoni G; Vivaldi C; Cappelli A; Vallati GE; Boni G; Cappelli F; Paladini A; Sciuto R; Masi G; Golfieri R; Cioni R
Cardiovasc Intervent Radiol; 2020 Sep; 43(9):1305-1314. PubMed ID: 32642986
[TBL] [Abstract][Full Text] [Related]
13. Modified response evaluation criteria in solid tumors and European Association for The Study of the Liver criteria using delayed-phase imaging at an early time point predict survival in patients with unresectable intrahepatic cholangiocarcinoma following yttrium-90 radioembolization.
Camacho JC; Kokabi N; Xing M; Prajapati HJ; El-Rayes B; Kim HS
J Vasc Interv Radiol; 2014 Feb; 25(2):256-65. PubMed ID: 24461131
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.
Zhao K; Erinjeri JP; Sotirchos VS; Alexander ES; Moussa AM; Marinelli B; Ziv E; Sofocleous CT; Abou-Alfa GK; Jarnagin WR; Karimi A; Yarmohammadi H
Abdom Radiol (NY); 2023 Jul; 48(7):2434-2442. PubMed ID: 37145313
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT).
Beuzit L; Edeline J; Brun V; Ronot M; Guillygomarc'h A; Boudjema K; Gandon Y; Garin E; Rolland Y
Eur J Radiol; 2016 Aug; 85(8):1445-52. PubMed ID: 27423686
[TBL] [Abstract][Full Text] [Related]
16. Conversion therapy for intrahepatic cholangiocarcinoma and tumor downsizing to increase resection rates: A systematic review.
Fruscione M; Pickens RC; Baker EH; Martinie JB; Iannitti DA; Hwang JJ; Vrochides D
Curr Probl Cancer; 2021 Feb; 45(1):100614. PubMed ID: 32622478
[TBL] [Abstract][Full Text] [Related]
17. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
18. Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survival.
Hoffmann RT; Paprottka PM; Schön A; Bamberg F; Haug A; Dürr EM; Rauch B; Trumm CT; Jakobs TF; Helmberger TK; Reiser MF; Kolligs FT
Cardiovasc Intervent Radiol; 2012 Feb; 35(1):105-16. PubMed ID: 21431970
[TBL] [Abstract][Full Text] [Related]
19. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinoma.
Yuan P; Song J; Wang F; Zhu G; Chen B
Invest New Drugs; 2022 Oct; 40(5):1125-1132. PubMed ID: 35793038
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic Cholangiocarcinoma Treated with Transarterial Yttrium-90 Glass Microsphere Radioembolization: Results of a Single Institution Retrospective Study.
Gangi A; Shah J; Hatfield N; Smith J; Sweeney J; Choi J; El-Haddad G; Biebel B; Parikh N; Arslan B; Hoffe SE; Frakes JM; Springett GM; Anaya DA; Malafa M; Chen DT; Chen Y; Kim RD; Shridhar R; Kis B
J Vasc Interv Radiol; 2018 Aug; 29(8):1101-1108. PubMed ID: 30042074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
